4//SEC Filing
Brandt Kevin D 4
Accession 0001235802-19-000104
CIK 0001453593other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:20 PM ET
Size
7.7 KB
Accession
0001235802-19-000104
Insider Transaction Report
Form 4
Brandt Kevin D
VP & Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2019-08-15+40,527→ 40,527 totalExercise: $2.76Exp: 2029-08-15→ Common Stock (40,527 underlying) - Award
Common Stock, $0.000001 par value
2019-08-15+35,169→ 75,169 total
Footnotes (3)
- [F1]These shares will vest and be issued with respect to 8,792 shares on each of August 15, 2020, August 15, 2021 and August 15, 2022 and with respect to 8,793 shares on August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
- [F2]These shares will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
- [F3]This option vests with respect to 10,131 shares on August 15, 2020 and with respect to 10,132 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001692661
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:20 PM ET
- Size
- 7.7 KB